# A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

> **NCT00235469** · PHASE2,PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 496 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** SPM 927

## Key facts

- **NCT ID:** NCT00235469
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2014-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235469, "A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00235469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*